Life sciences · Review
Cancer and Metastasis Reviews · October 24, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Review.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
The metastatic cascade describes the series of steps by which cancer cells travel from the tumor of origin to a distant site of metastasis. Successful colonization and formation of macrometastases are generally regarded as the terminus of the metastatic cascade. However, a growing body of literature points to the importance of inter- and intra-tumoral heterogeneity during the growth of established metastases, which manifests as distinct histopathological growth patterns (HGPs). HGPs refer to the dynamic interface between cancer cells, stromal cells and parenchymal cells within the metastasis-bearing organ. In several metastatic niches, such as the liver and brain, unique HGPs have been described that reveal aspects of intrinsic disease biology and have important implications for patient survival and therapy response. With emerging technologies, recent studies have revealed spatial insights pertaining to cancer cell—tumor microenvironment interactions at distinct metastatic sites. Herein, we describe the clinical and biological relevance of the dynamic interplay between cancer cells and the native liver or brain cells in the context of metastases from adult solid tumors. When applicable, we draw comparisons between metastatic sites and identify common themes by which HGP and components of the tumor microenvironment can be exploited for therapeutic intervention.